Seven French Health Competitiveness Clusters Combine to Create a Network

Seven French health competitiveness clusters—Alsace Biovalley, Atlanpole Biotherapies, Cancer-Bio-Santé, Eurobiomed, Lyonbiopole, Medicen Paris Region and Nutrition-Health-Longevity (NSL) now has more than 120 members from the agrifood, pharmaceutical and biotechnology sectors, as well as research centers invested in the field of health nutrition. At the crossroads of new medical, scientific and industrial strategies, NSL has become a key player in its field of expertise for networking private research and public research. Its mission is to contribute to the development of its members in two fast-growing markets: foods and functional ingredients and drug treatments for metabolic diseases and pathologies related to aging. Since the creation of the cluster in 2005, 250 projects have been certified, more than 100 of them have obtained an average funding of 1 million euros ($1.2 million). The NSL Pole has supported more than 20 projects in the Investment of the Future Program for a total funding of 150 million euros ($185 million), including support for academic research excellence on diabetes and neurodegenerative diseases. It helped bring more than 30 products and services to market.